UF Innovate Ventures has contributed to a series B round for StrideBio, partially based on research into gene therapies at University of Florida.

Novo Nordisk, Insulet and Mayo Clinic helped the diabetes monitoring technology provider push its overall funding past $100m.

D1 Capital Partners has led a $102m series D round for Inflammatix, whose existing shareholders include Stanford-StartX Fund.

Binoy Bhansali was previously at Sandbox Industries, which manages $1.2bn across four funds for health insurer Blue Cross Blue Shield.

Q&A with Kurt Sheline, principal, Echo Health Ventures

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The money will fund the progress of the University of London-linked precision medicine developer's lead drug candidate into the clinic.

Konishiyasu and Sojitz contributed to a series A round for the cancer vaccine developer, which expanded to their home of Japan last year.

SoftBank Vision Fund 2, Itochu and an unnamed insurer took part in a series C round that hiked the gene and cell therapy developer's total funding to $845m.

IBM Ventures participated in a $20m round for the neurological disease diagnostics technology developer, a spinout from Tel Aviv University.